Jinyu Bio-Technology Hits Day Low of CNY 11.63 Amid Price Pressure

Jinyu Bio-Technology Co., Ltd. experienced a notable decline today, with the stock dropping by 3.63% and reaching an intraday low of CNY 11.63. This performance stands in contrast to the China Shanghai Composite, which fell by only 0.73% on the same day. Over the past week, Jinyu's stock has decreased by 9.25%, and its monthly performance shows a significant drop of 16.82%. Despite a strong annual return of 60.97%, the company has faced challenges in recent quarters, reporting negative results for four consecutive periods. Key financial metrics indicate a low Return on Capital Employed (ROCE) of 6.64%, reflecting limited profitability relative to total capital. Additionally, the company has seen a decline in net sales at an annual rate of 1.07% and a staggering drop in operating profit of 166.78% over the last five years. With a market capitalization of CNY 16,806 million, Jinyu Bio-Technology operates within the Pharmaceuticals & Biotechnology sector. The stock's high P/E ratio of 188.00 and a Price to Book ratio of 3.08 suggest a premium valuation, despite recent performance trends.